AtonRa Partners’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $420K | Sell |
7,498
-796
| -10% | -$44.5K | 0.84% | 51 |
|
|
2023
Q3 | $342K | Sell |
8,294
-1,088
| -12% | -$44.9K | 0.72% | 68 |
|
|
2023
Q2 | $524K | Sell |
9,382
-868
| -8% | -$48.5K | 0.81% | 50 |
|
|
2023
Q1 | $572K | Sell |
10,250
-1,303
| -11% | -$72.7K | 0.83% | 43 |
|
|
2022
Q4 | $421K | Sell |
11,553
-3,125
| -21% | -$114K | 0.54% | 81 |
|
|
2022
Q3 | $418K | Buy |
14,678
+3,649
| +33% | +$104K | 0.41% | 103 |
|
|
2022
Q2 | $499K | Buy |
11,029
+2,292
| +26% | +$104K | 0.46% | 101 |
|
|
2022
Q1 | $665K | Sell |
8,737
-1,460
| -14% | -$111K | 0.36% | 99 |
|
|
2021
Q4 | $1.52M | Sell |
10,197
-4,281
| -30% | -$638K | 0.53% | 67 |
|
|
2021
Q3 | $2.11M | Buy |
14,478
+1,345
| +10% | +$196K | 0.7% | 59 |
|
|
2021
Q2 | $2.57M | Buy |
13,133
+360
| +3% | +$70.5K | 0.94% | 50 |
|
|
2021
Q1 | $2.31M | Buy |
+12,773
| New | +$2.31M | 1.03% | 43 |
|